Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sangbin Lim

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Hepatology (Baltimore, Md.)|July 13, 2011
Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humansYeonghwan Kim, Miran Jang, Sangbin Lim, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|December 20, 2011
Mitochondria-targeted antioxidants protect pancreatic β-cells against oxidative stress and improve insulin secretion in glucotoxicity and glucolipotoxicitySangbin Lim, Md Abdur Rashid, Miran Jang, et al.
BMC Medicine|August 7, 2013
Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokinesAmarjargal Dashdorj, K R Jyothi, Sangbin Lim, et al.
Therapeutic Advances in Medical Oncology|March 7, 2022
Molecular landscape of osimertinib resistance in patients and patient-derived preclinical modelsSun Min Lim, San-Duk Yang, Sangbin Lim, et al.
The International Journal of Biochemistry & Cell Biology|June 5, 2013
Carbonyl reductase 1 is an essential regulator of skeletal muscle differentiation and regenerationSangbin Lim, Ju Young Shin, Ara Jo, et al.
Cancer Research|May 20, 2016
Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1αSangbin Lim, Hao Liu, Luciana Madeira da Silva, et al.
British Journal of Cancer|September 23, 2024
SON is an essential RNA splicing factor promoting ErbB2 and ErbB3 expression in breast cancerJoshua B Phillips, Seong-Sik Park, Cheng-Han Lin, et al.
Antioxidants & Redox Signaling|July 1, 2016
Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer TreatmentAra Jo, Tae Gyu Choi, Yong Hwa Jo, et al.
Journal of Medicinal Chemistry|November 28, 2015
Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus InfectionsSuhui Yang, Jyothi K R, Sangbin Lim, et al.
Cancer Discovery|May 17, 2020
Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-MET Bispecific Antibody, in Diverse Models of <i>EGFR</i> Exon 20 Insertion-Driven NSCLCJiyeon Yun, Soo-Hwan Lee, Seok-Young Kim, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Hepatology (Baltimore, Md.)|July 13, 2011
Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humansYeonghwan Kim, Miran Jang, Sangbin Lim, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|December 20, 2011
Mitochondria-targeted antioxidants protect pancreatic β-cells against oxidative stress and improve insulin secretion in glucotoxicity and glucolipotoxicitySangbin Lim, Md Abdur Rashid, Miran Jang, et al.
BMC Medicine|August 7, 2013
Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokinesAmarjargal Dashdorj, K R Jyothi, Sangbin Lim, et al.
Therapeutic Advances in Medical Oncology|March 7, 2022
Molecular landscape of osimertinib resistance in patients and patient-derived preclinical modelsSun Min Lim, San-Duk Yang, Sangbin Lim, et al.
The International Journal of Biochemistry & Cell Biology|June 5, 2013
Carbonyl reductase 1 is an essential regulator of skeletal muscle differentiation and regenerationSangbin Lim, Ju Young Shin, Ara Jo, et al.
Cancer Research|May 20, 2016
Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1αSangbin Lim, Hao Liu, Luciana Madeira da Silva, et al.
British Journal of Cancer|September 23, 2024
SON is an essential RNA splicing factor promoting ErbB2 and ErbB3 expression in breast cancerJoshua B Phillips, Seong-Sik Park, Cheng-Han Lin, et al.
Antioxidants & Redox Signaling|July 1, 2016
Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer TreatmentAra Jo, Tae Gyu Choi, Yong Hwa Jo, et al.
Journal of Medicinal Chemistry|November 28, 2015
Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus InfectionsSuhui Yang, Jyothi K R, Sangbin Lim, et al.
Cancer Discovery|May 17, 2020
Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-MET Bispecific Antibody, in Diverse Models of <i>EGFR</i> Exon 20 Insertion-Driven NSCLCJiyeon Yun, Soo-Hwan Lee, Seok-Young Kim, et al.
Pageof 3